- Home
- RVMD vs NLY Comparison
RVMD vs NLY Comparison
Compare RVMD & NLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- NLY
- Stock Information
- Founded
- RVMD 2014
- NLY 1996
- Country
- RVMD United States
- NLY United States
- Employees
- RVMD N/A
- NLY N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- NLY Real Estate Investment Trusts
- Sector
- RVMD Health Care
- NLY Real Estate
- Exchange
- RVMD Nasdaq
- NLY Nasdaq
- Market Cap
- RVMD 8.7B
- NLY 10.3B
- IPO Year
- RVMD 2020
- NLY 1997
- Fundamental
- Price
- RVMD $40.16
- NLY $19.51
- Analyst Decision
- RVMD Strong Buy
- NLY Strong Buy
- Analyst Count
- RVMD 13
- NLY 11
- Target Price
- RVMD $65.15
- NLY $21.20
- AVG Volume (30 Days)
- RVMD 1.3M
- NLY 7.8M
- Earning Date
- RVMD 02-24-2025
- NLY 01-29-2025
- Dividend Yield
- RVMD N/A
- NLY 13.36%
- EPS Growth
- RVMD N/A
- NLY N/A
- EPS
- RVMD N/A
- NLY N/A
- Revenue
- RVMD $742,000.00
- NLY $369,368,000.00
- Revenue This Year
- RVMD N/A
- NLY N/A
- Revenue Next Year
- RVMD $1,855.56
- NLY $9.79
- P/E Ratio
- RVMD N/A
- NLY N/A
- Revenue Growth
- RVMD N/A
- NLY N/A
- 52 Week Low
- RVMD $26.56
- NLY $17.67
- 52 Week High
- RVMD $62.40
- NLY $21.11
- Technical
- Relative Strength Index (RSI)
- RVMD 31.31
- NLY 59.28
- Support Level
- RVMD $39.48
- NLY $17.76
- Resistance Level
- RVMD $42.97
- NLY $19.04
- Average True Range (ATR)
- RVMD 1.48
- NLY 0.32
- MACD
- RVMD -0.07
- NLY 0.13
- Stochastic Oscillator
- RVMD 13.59
- NLY 98.87
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
About NLY Annaly Capital Management Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. The Company owns a portfolio of real estate related investments, including mortgage pass-through certificates, collateralized mortgage obligations, credit risk transfer securities, other securities representing interests in or obligations backed by pools of mortgage loans, residential mortgage loans and mortgage servicing rights. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The Company's three investment groups are comprised of the following: Annaly Agency Group, Annaly Residential Credit Group, Annaly Mortgage Servicing Rights Group.